Young Adult Case of Fontan-associated Liver Disease with Hepatocellular Carcinoma During the Transition from Pediatric to Internal Medicine Care and Follow-up-Reference-Cited by-同舟云学术

Young Adult Case of Fontan-associated Liver Disease with Hepatocellular Carcinoma During the Transition from Pediatric to Internal Medicine Care and Follow-up

Published:2023 Issue:3 Volume:69 Page:246-251
ISSN:2187-9737
Container-title:Juntendo Medical Journal
language:en
Short-container-title:Juntendo Medical Journal

Author:

FUKUNAGA HIDEO¹,SUZUKI MITSUYOSHI¹,SATO KEIYA¹,MIYAZAKI SAKIKO²,UCHIYAMA AKIRA³,YAMASHINA SHUNPEI³,MIYASHITA MAMIKO⁴,TAKAHASHI KEN¹,SHIMIZU TOSHIAKI¹

Affiliation:

1. Department of Pediatrics, Juntendo University Faculty of Medicine

2. Department of Cardiology, Juntendo University Faculty of Medicine

3. Department of Gastroenterology, Juntendo University Faculty of Medicine

4. Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Faculty of Medicine

Publisher

The Jutendo Medical Journal

Subject

General Agricultural and Biological Sciences

Link

https://www.jstage.jst.go.jp/article/jmj/69/3/69_JMJ22-0037-CR/_pdf

Reference20 articles.

1. [1] Warnes CA, Williams RG, Bashore TM, et al: ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008; 52: e143-e263.

2. [2] Kogiso T, Tokushige K: Fontan-associated liver disease and hepatocellular carcinoma in adults. Sci Rep. 2020; 10: 21742.

3. [3] Gordon-Walker TT, Bove K, Veldtman G: Fontan-associated liver disease: A review. J Cardiol. 2019; 74: 223-232.

4. [4] Kogiso T, Sagawa T, Taniai M, et al: Risk factors for Fontan-associated hepatocellular carcinoma. PLoS One. 2022; 17: e0270230.

5. [5] Kuwabara M, Niwa K, Toyoda T, et al: Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure- A Nationwide Survey in Japan. Circ J. 2018; 82: 1155-1160.